Fig. 1From: Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategySchematic of ECM-degrading cell therapy applied to fibrosis. During fibrosis, the ECM is excessively secreted and deposited. Delivery of ECM-degrading cells to fibrotic organs or tissues can degrade the deposited ECM mainly by secreting MMPs, which are expected to  reduce excessive fibrosisBack to article page